Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
3.940
+0.250 (6.78%)
May 15, 2026, 4:00 PM EDT - Market closed
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $6.37 million as of May 15, 2026. Its market cap has decreased by -18.13% in one year.
Market Cap
6.37M
Enterprise Value
-3.88M
1-Year Change
-18.13%
Ranking
Category
Stock Price
$3.94
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $6.37M, an increase of 28.20%. That is a compound annual growth rate of 1.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 6.37M | -8.91% |
| Dec 31, 2025 | 7.00M | -36.83% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptorum Group | 6.89M |
| Immuron | 6.60M |
| XTL Biopharmaceuticals | 6.52M |
| TransCode Therapeutics | 6.45M |
| Silo Pharma | 6.41M |
| Moolec Science | 6.16M |
| MetaVia | 6.15M |
| CollPlant Biotechnologies | 6.05M |